Profund Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
Profund Advisors's IMVT Position: Q3 2026 in Review
Profund Advisors reduced its Immunovant (IMVT) stake by 10% in Q3 2026, selling an estimated $150K and leaving 32,693 shares worth $1.1M. The position accounts for 0.03% of the portfolio, ranked #334.
Profund Advisors first reported a position in IMVT in Q1 2023 and has held it in 15 quarters since. The position peaked at $1.91M in Q3 2023. 46 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Profund Advisors held 32,693 shares of Immunovant worth $1.1M as of Q3 2026.
- Profund Advisors sold 3,817 Immunovant shares in Q3 2026, an estimated $150K.
- Immunovant made up 0.03% of Profund Advisors's portfolio in Q3 2026, its #334 holding.
- Profund Advisors first reported a position in Immunovant in Q1 2023 and has held it in 15 quarters since.
- Profund Advisors's Immunovant position peaked at $1.91M in Q3 2023.
- 46 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.